Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia

被引:0
|
作者
Zhao Bing
Li Mengjiao
Ling Yun
Peng Yibing
Huang Jun
Qu Hongping
Gao Yuan
Li Yingchuan
Hu Bijie
Lu Shuihua
Lu Hongzhou
Zhang Wenhong
Mao Enqiang
机构
[1] Shanghai Public Health Clinical Center
[2] Shanghai 200032
[3] ChinaDepartment of Infectious Disease
[4] Shanghai 201508
[5] Renji Hospital
[6] Zhongshan Hospital
[7] Shanghai Jiao Tong University School of Medicine
[8] ChinaShanghai Institute of Hypertension
[9] Shanghai 200025
[10] Shanghai Jiaotong University School of Medicine
[11] Shanghai 200233
[12] ChinaDepartment of Critical Care Medicine
[13] ChinaTuberculosis Department of Shanghai Public Health Clinical Center
[14] Shanghai 200217
[15] The Sixth People’’s Hospital
[16] Department of Emergency
[17] Shanghai 200040
[18] ChinaDepartment of Infectious Disease of Shanghai Huashan Hospital
[19] ChinaDepartment of Laboratory Medicine
[20] Ruijin Hospital
[21] ChinaDepartment of Emergency
[22] Fudan University
关键词
D O I
暂无
中图分类号
R563.1 [肺炎];
学科分类号
摘要
The coronavirus disease 2019 (COVID-19) has been declared as a pandemic by the World Health Organization.[1] Most COVID-19 patients exhibit mild to moderate symptoms, while approximately 15% progress
引用
收藏
页码:23 / 25
页数:3
相关论文
共 50 条
  • [1] Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia
    Zhao, Bing
    Li, Mengjiao
    Ling, Yun
    Peng, Yibing
    Huang, Jun
    Qu, Hongping
    Gao, Yuan
    Li, Yingchuan
    Hu, Bijie
    Lu, Shuihua
    Lu, Hongzhou
    Zhang, Wenhong
    Mao, Enqiang
    CHINESE MEDICAL JOURNAL, 2022, 135 (01) : 23 - 25
  • [2] High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019
    Xia, Guozhi
    Fan, Di
    He, Yanru
    Zhu, Yaohu
    Zheng, Qiangsun
    NUTRITION, 2021, 91-92
  • [3] The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis
    Kwak, Sang Gyu
    Choo, Yoo Jin
    Chang, Min Cheol
    COMPLEMENTARY THERAPIES IN MEDICINE, 2022, 64
  • [4] High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
    Cao, Wei
    Liu, Xiaosheng
    Bai, Tao
    Fan, Hongwei
    Hong, Ke
    Song, Hui
    Han, Yang
    Lin, Ling
    Ruan, Lianguo
    Li, Taisheng
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (03): : 1 - 6
  • [5] High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
    Cao, Wei
    Liu, Xiaosheng
    Hong, Ke
    Ma, Zhiyong
    Zhang, Yuelun
    Lin, Ling
    Han, Yang
    Xiong, Yong
    Liu, Zhengyin
    Ruan, Lianguo
    Li, Taisheng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
    Erdogan, Cem
    Ciftci, Bahadir
    Kizilaslan, Deniz
    Ekinci, Mursel
    Iptec, Gulsen
    Gemici, Ali Ihsan
    Karaaslan, Pelin
    AIN SHAMS JOURNAL OF ANESTHESIOLOGY, 2020, 12 (01)
  • [7] High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
    Cem Erdogan
    Bahadir Ciftci
    Deniz Kizilaslan
    Mursel Ekinci
    Gülsen İptec
    Ali İhsan Gemici
    Pelin Karaaslan
    Ain-Shams Journal of Anesthesiology, 12
  • [8] Review of high-dose intravenous vitamin C as an anticancer agent
    Wilson, Michelle K.
    Baguley, Bruce C.
    Wall, Clare
    Jameson, Michael B.
    Findlay, Michael P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (01) : 22 - 37
  • [9] Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia
    Suna, Kavurgaci
    Melahat, Uzel Sener
    Murat, Yildiz
    Figen, Ozturk Ergur
    Ayperi, Oztuerk
    MEDICINA CLINICA, 2022, 158 (08): : 356 - 360
  • [10] Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
    Suzuki, Yasuhito
    Tanino, Yoshinori
    Nikaido, Takefumi
    Minemura, Hiroyuki
    Umeda, Takashi
    Rikimaru, Mami
    Onuma, Takumi
    Naito, Shotaro
    Takiguchi, Yoshinori
    Tomita, Hikaru
    Kawamata, Takaya
    Togawa, Ryuichi
    Sato, Yuki
    Uematsu, Manabu
    Morimoto, Julia
    Kitakawa, Kadzuhiro
    Tsukada, Yasuhiko
    Nakamura, Kiwamu
    Kanemitsu, Keiji
    Iseki, Ken
    Shibata, Yoko
    INTERNAL MEDICINE, 2021, 60 (03) : 457 - 461